How many institutions own HROWM stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own HROWM shares is N/A, representing N/A of the company's common stock.

Who are the major shareholders selling Harrow Health, Inc. 11.875% Senior Notes due 2027 stock?

N/A, in the last quarter, reduced its stake in HROWM by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the HROWM shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned HROWM shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying HROWM stock?

As per its latest 13F filing, N/A increased its stake in HROWM by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of HROWM to its portfolio, raising its holding to - shares of worth -. N/A also increased its HROWM shares holding by N/A which brought its holding to - shares worth -.

HROWM's major insiders: who are they?

The insider with the most stakes in HROWM is Opaleye Management Inc. , 10 percent owner at the company. Additionally, HROWM stock is highly held by Chief Executive Officer BAUM MARK L and director Makary Martin A. among others.

Did an insider recently sell HROWM stock?

Company executives, directors, and other insiders own N/A percent of Harrow Health, Inc. 11.875% Senior Notes due 2027's stock. Within the last six months, there have been 0 transaction(s) in which HROWM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include LINDSTROM RICHARD L MD.

Which insider recently purchased HROWM stock?

There have been 0 transaction(s) during the past 6-months in which Harrow Health, Inc. 11.875% Senior Notes due 2027 insiders have bought stock, totalling 0 shares

How much of HROWM does insiders own?

Around 0 Harrow Health, Inc. 11.875% Senior Notes due 2027 shares are held by insiders, which represents about N/A of HROWM stock.

Who is the insider with the largest stake?

HROWM 10 percent owner, Opaleye Management Inc. holds the largest portfolio of the company's shares. HROWM shares owned by Opaleye total nearly 3.65 million.

Which institution holds the most shares in HROWM?

N/A is the largest institutional owner in HROWM which holds - shares worth - or N/A of the total HROWM shares outstanding followed by N/A with ownership of - shares representing N/A of the HROWM ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Is Harrow Health, Inc. 11.875% Senior Notes due 2027 stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the HROWM is concerned, it is a stock which is optionable.

Is there a short position on HROWM's shares?

Number of HROWM shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding HROWM shares are there?

As of today, N/A shares of HROWM are outstanding.

Is there many float in HROWM stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, HROWM has N/A shares in float.

HROWM short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for HROWM is N/A.

Stock Ideas

HROWM Stock Ownership Breakdown

NASDAQ : HROWM

Harrow Health 11875% Senior Notes due 2027

$26.03

-0.02-0.08%

At Close 4:00 PM

Not Actively Trading

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

N/A

Short % of Float

N/A

Short % of Shares Outstanding

Institutional Ownership

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
No Data

Insiders

Among the HROWM insiders holding of N/A of the stake in company, OPALEYE MANAGEMENT INC., 10 percent owner, holds the largest shares of 3.65M. BAUM MARK L, Chief Executive Officer, is the second largest HROWM insider with ownership of 2.02M shares. MAKARY MARTIN A., director, stands third with possession of 45K shares of that stake.

Insiders	Designation	Shares Held
OPALEYE MANAGEMENT INC.	10 percent owner	3.65M
BAUM MARK L	Chief Executive Officer	2.02M
MAKARY MARTIN A.	director	45K
LINDSTROM RICHARD L MD	director	26.1K
SPARKS TERESA	director	7.74K
STERNBERG PERRY J.	director	7.74K
VAN HORN R. LAWRENCE	director	7.74K
BOLL ANDREW R.	Chief Financial Officer	0
SAHAREK JOHN P.	Chief Commercial Officer	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 16, 2023	BAUM MARK L	PURCHASE	8.11	7.5K	60.83K	2.02M
Nov 15, 2023	OPALEYE MANAGEMENT INC.	PURCHASE	8.03	25K	200.74K	3.65M
Nov 10, 2023	SAHAREK JOHN P.		4.16	20K	83.2K	0
Sep 20, 2023	OPALEYE MANAGEMENT INC.	PURCHASE	14.49	5.98K	86.71K	3.62M
Sep 19, 2023	OPALEYE MANAGEMENT INC.	PURCHASE	14.65	14.02K	205.37K	3.61M
Aug 14, 2023	MAKARY MARTIN A.	PURCHASE	16.92	20K	338.4K	45K
Aug 14, 2023	BAUM MARK L	PURCHASE	17.05	5.8K	98.89K	2.02M
Jul 18, 2023	BAUM MARK L		0.00	762.3K	-	0
Jul 18, 2023	SAHAREK JOHN P.		0.00	277.2K	-	0
Jul 18, 2023	BOLL ANDREW R.		0.00	346.5K	-	0
Jun 21, 2023	MAKARY MARTIN A.	AWARD	0.00	7.74K	-	7.74K
Jun 21, 2023	SPARKS TERESA	AWARD	0.00	7.74K	-	7.74K
Jun 21, 2023	STERNBERG PERRY J.	AWARD	0.00	7.74K	-	7.74K
Jun 21, 2023	VAN HORN R. LAWRENCE	AWARD	0.00	7.74K	-	7.74K
Apr 03, 2023	BAUM MARK L	AWARD	0.00	762.3K	-	762.3K
Apr 03, 2023	BOLL ANDREW R.	AWARD	0.00	346.5K	-	346.5K
Apr 03, 2023	SAHAREK JOHN P.	AWARD	0.00	277.2K	-	277.2K
Mar 31, 2023	BOLL ANDREW R.		6.00	90K	540K	0
Jan 02, 2023	BAUM MARK L		0.00	88K	-	0
Jan 02, 2023	BOLL ANDREW R.		0.00	23K	-	0
Dec 22, 2022	VAN HORN R. LAWRENCE	PURCHASE	13.42	1.86K	24.96K	1.86K
Dec 22, 2022	BOLL ANDREW R.	PURCHASE	13.54	2.5K	33.85K	255.06K
Dec 22, 2022	BAUM MARK L	PURCHASE	13.39	25K	334.75K	1.43M
Dec 21, 2022	MAKARY MARTIN A.	PURCHASE	13.37	25K	334.25K	25K
Dec 14, 2022	OPALEYE MANAGEMENT INC.	PURCHASE	10.52	16.18K	170.25K	175K
Sep 30, 2022	LINDSTROM RICHARD L MD	SALE	12.62	40K	504.8K	26.1K
Sep 28, 2022	OPALEYE MANAGEMENT INC.	PURCHASE	9.77	1.09K	10.61K	158.82K
Jun 09, 2022	MAKARY MARTIN A.	AWARD	0.00	13.12K	-	13.12K
Jun 09, 2022	SPARKS TERESA	AWARD	0.00	13.12K	-	13.12K
Jun 09, 2022	STERNBERG PERRY J.	AWARD	0.00	13.12K	-	13.12K
Jun 09, 2022	VAN HORN R. LAWRENCE	AWARD	0.00	13.12K	-	13.12K
Jun 09, 2022	LINDSTROM RICHARD L MD	AWARD	0.00	13.12K	-	13.12K
Apr 13, 2022	OPALEYE MANAGEMENT INC.	PURCHASE	6.76	2.83K	19.15K	157.73K
Apr 12, 2022	OPALEYE MANAGEMENT INC.	PURCHASE	6.75	3.56K	24K	154.9K
Feb 19, 2022	SAHAREK JOHN P.		0.00	50K	-	0
Feb 19, 2022	BOLL ANDREW R.		0.00	50K	-	0
Jan 28, 2022	OPALEYE MANAGEMENT INC.	PURCHASE	6.89	1.34K	9.25K	150K
Jan 20, 2022	BAUM MARK L		2.40	125K	300K	0
Sep 24, 2021	LINDSTROM RICHARD L MD	SALE	10.04	3.9K	39.16K	66.1K
Sep 16, 2021	LINDSTROM RICHARD L MD	SALE	9.02	5.84K	52.68K	70K
Sep 15, 2021	LINDSTROM RICHARD L MD	SALE	9.09	14.16K	128.71K	75.84K
Aug 19, 2021	OPALEYE MANAGEMENT INC.	PURCHASE	8.45	2.5K	21.11K	150K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.